Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology - United States
doi 10.1002/hep.29407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)

Cytoskeleton
Cell BiologyStructural Biology
2018English

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
2013English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

PLK1 (Polo-Like Kinase 1 (Drosophila))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2010English

Bioorthogonal Probes for Polo-Like Kinase 1 Imaging and Quantification

Angewandte Chemie
2011English

Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536

Haematologica
Hematology
2011English

A 3′UTR Polymorphism Modulates mRNA Stability of the Oncogene and Drug Target Polo-Like Kinase 1

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy